|
RALB expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.981020E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.193560E-01 |
| Normal-vs-Stage2 |
4.526000E-01 |
| Normal-vs-Stage3 |
5.704200E-01 |
| Normal-vs-Stage4 |
2.954600E-01 |
| Stage1-vs-Stage2 |
1.599990E-01 |
| Stage1-vs-Stage3 |
6.194000E-01 |
| Stage1-vs-Stage4 |
9.081600E-01 |
| Stage2-vs-Stage3 |
2.965800E-01 |
| Stage2-vs-Stage4 |
2.583000E-01 |
| Stage3-vs-Stage4 |
6.383000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.526800E-01 |
| Normal-vs-AfricanAmerican |
3.278600E-01 |
| Normal-vs-Asian |
6.045800E-01 |
| Caucasian-vs-AfricanAmerican |
9.535600E-01 |
| Caucasian-vs-Asian |
7.655600E-01 |
| AfricanAmerican-vs-Asian |
7.281800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.573910E-02 |
| Normal-vs-Female |
1.422210E-01 |
| Male-vs-Female |
1.360670E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.522500E-02 |
| Normal-vs-Extreme_Weight |
9.340100E-03 |
| Normal-vs-Obese |
7.771600E-01 |
| Normal-vs-Extreme_Obese |
4.979800E-01 |
| Normal_Weight-vs-Extreme_Weight |
7.701000E-01 |
| Normal_Weight-vs-Obese |
6.480300E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.109200E-01 |
| Extreme_Weight-vs-Obese |
5.057800E-02 |
| Extreme_Weight-vs-Extreme_Obese |
7.999400E-01 |
| Obese-vs-Extreme_Obese |
4.779000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.455200E-01 |
| Normal-vs-Age(41-60Yrs) |
8.532000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.010440E-01 |
| Normal-vs-Age(81-100Yrs) |
7.361800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.382000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.489400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
7.638200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.012800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.124000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.511200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.885000E-01 |
| Normal-VS-Type2 PRCC |
8.672400E-01 |
| Normal-VS-KIRP CIMP |
7.788800E-01 |
| Normal-VS-Unclassified PRCC |
7.698800E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.325800E-01 |
| Type1 PRCC-VS-KIRP CIMP |
6.344000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
8.067000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
9.550000E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.935000E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
9.210000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.827800E-02 |
| Normal-vs-N1 |
8.483800E-01 |
| Normal-vs-N2 |
2.136400E-02 |
| N0-vs-N1 |
3.123200E-01 |
| N0-vs-N2 |
7.212600E-01 |
| N1-vs-N2 |
2.978000E-01 |
|
|
